The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 13, 2010

Filed:

Mar. 19, 2003
Applicants:

Sujit K. Basu, Cambridge, MA (US);

Giovanni Caponetti, Piacenza, IT;

Robert Clarke, Canton, MA (US);

Katharina J. Elbert, Cambridge, MA (US);

Inventors:

Sujit K. Basu, Cambridge, MA (US);

Giovanni Caponetti, Piacenza, IT;

Robert Clarke, Canton, MA (US);

Katharina J. Elbert, Cambridge, MA (US);

Assignee:

Alkermes, Inc., Waltham, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/16 (2006.01); A61K 9/12 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention is based, in part, on the unexpected discovery that particles for pulmonary delivery of a therapeutic, prophylactic or diagnostic agent that comprise a phospholipid and a sufficient amount of leucine can produce sustained effect of the agent. Specifically, particles for pulmonary delivery of a therapeutic, prophylactic or diagnostic agent that contain a phospholipid or combination of phospholipids, wherein the phospholipid or combination of phospholipids is present in the particles in an amount of about 1 to 46 weight percent; and leucine, wherein leucine is present in the particles in an amount of at least 46 weight percent, can contribute to sustained effect of the agent. Particles that comprise at least 46 weight percent leucine but that do not contain phospholipids do not exhibit these same sustained effect properties.


Find Patent Forward Citations

Loading…